Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus

Trial Profile

Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Riboflavin (Primary)
  • Indications Keratoconus
  • Focus Therapeutic Use
  • Sponsors Avedro
  • Most Recent Events

    • 19 Jul 2016 According to an Avedro media release, the US FDA has approved Photrexa Viscous, Photrexa and KXL system used in corneal collagen cross-linking for the treatment of corneal ectasia following refractive surgery based on data from this and two other phase III trials.
    • 06 Jul 2016 The study design has changed from cross-over assignment to parallel assignment.
    • 12 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top